Kiro provides an AI-driven platform that enhances the accessibility and interpretation of medical biology results for laboratories, healthcare professionals, and patients. By transforming complex data into interactive and personalized formats, Kiro improves communication and understanding in the medical care process.
Funding
$17M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Medical biology results are often presented in complex formats that are difficult for both healthcare professionals and patients to interpret. This complexity can hinder effective communication and understanding of critical health information, potentially impacting patient care.
Solution
Kiro offers an AI-powered platform designed to enhance the accessibility and interpretation of medical biology results. The platform transforms complex data into interactive and personalized formats, making it easier for laboratories, healthcare professionals, and patients to understand. By providing visual and intuitive displays of results, Kiro aims to improve communication and facilitate better-informed decision-making in the medical care process. The platform supports secure access to reports on any device, allowing users to retrieve and interpret their results quickly and easily.
Target Audience
Kiro's primary users include medical biology laboratories, healthcare professionals, and patients seeking to improve their understanding and interpretation of medical test results.
Features
- Interactive and visual displays of medical biology results
- Personalized experiences for patients and healthcare professionals based on individual biological profiles
- Secure platform ensuring data protection and privacy, adhering to national and European standards
- Accessible reports available on any device
- AI-driven analysis to highlight pertinent information and simplify complex data